Skip to main content
Erschienen in: Reactions Weekly 1/2017

01.09.2017 | Case report

Dabrafenib/trametinib

Recurrent tattoo reaction: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

A 42-year-old woman developed recurrent tattoo reaction during therapy with dabrafenib and trametinib [routes, dosages and durations of treatment to reactions onset not stated]. …
Literatur
Zurück zum Zitat Reinhard R, et al. Recurrent tattoo reactions in a patient treated with braf and mek inhibitor combination therapy. Journal der Deutschen Dermatologischen Gesellschaft 14: 45, No. 4, Sep 2016. Available from: URL: http://doi.org/10.1111/ddg.13115 [abstract] - Germany Reinhard R, et al. Recurrent tattoo reactions in a patient treated with braf and mek inhibitor combination therapy. Journal der Deutschen Dermatologischen Gesellschaft 14: 45, No. 4, Sep 2016. Available from: URL: http://​doi.​org/​10.​1111/​ddg.​13115 [abstract] - Germany
Metadaten
Titel
Dabrafenib/trametinib
Recurrent tattoo reaction: case report
Publikationsdatum
01.09.2017
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2017
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-017-35991-9

Weitere Artikel der Ausgabe 1/2017

Reactions Weekly 1/2017 Zur Ausgabe

Case report

Rifampicin

Case report

Cariprazine